Does third-party review replace the FDA's role in 510(k) clearance?

No, third-party review does not replace the FDA's role. The third-party organization provides a recommendation, but the FDA still conducts a final administrative review and issues the clearance letter.

What are the benefits of using a Third-Party Review Organization?

The primary benefit is the potential for reduced review times compared to direct FDA review, especially for straightforward devices, as well as accessing specialized expertise from the third-party reviewer.

Are all Third-Party Review Organizations the same?

No, while all are FDA-accredited, they may have different areas of expertise or specific product codes they are authorized to review. Manufacturers should select an organization appropriate for their device.

All terms

RegulatoryRegulated Pathways Global Markets3P 510(k)

Third-Party Review of 510(k)

Program in which FDA-accredited third parties conduct the initial 510(k) review for eligible device types.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed September 19, 2026

Definition

Eligible Class I and Class II device 510(k)s can be reviewed by an FDA-accredited Third Party Review Organization, which submits a recommendation to FDA. Final clearance still rests with FDA. FDA usually decides within 30 days of receiving the recommendation. Eligible device types are listed on FDA's website, and the review organization charges its own fee in place of the FDA user fee.

What the regulation says

The FDA Modernization Act of 1997 authorized the third-party review program for 510(k) submissions, as outlined in FDA guidance documents like "Guidance for Industry and FDA Staff Third Party Review Programs" (2018). This program allows accredited third parties to conduct the primary review of certain low-to-moderate risk medical devices, aiming to expedite the regulatory process while the FDA retains final clearance authority. The scope and eligibility criteria for devices are specified by the FDA, with only a subset of Class I and Class II devices qualifying.

What this means in practice

Used to compress timelines for well-established product types; not all product codes are eligible.

Examples

A manufacturer of a new, conventional blood glucose meter opts for third-party review to potentially accelerate its 510(k) clearance process.
A company developing a surgical tool with a well-established predicate device chooses a Third-Party Review Organization to handle the initial technical review of their 510(k) submission.
A medical device startup with limited internal regulatory resources uses a third-party reviewer to leverage their expertise and streamline the 510(k) submission for a Class II diagnostic imaging accessory.

Common pitfalls

•A common pitfall is submitting an eligible 510(k) to a Third-Party Review Organization without ensuring the device falls within the specific product codes and limitations accepted by that particular organization.
•Another mistake is assuming that third-party review guarantees faster clearance, as the FDA still performs an administrative review and can request additional information, impacting the overall timeline.
•Companies sometimes fail to perform due diligence on the accreditation and experience of a Third-Party Review Organization, potentially leading to incomplete reviews or delays.
•Misunderstanding that the third-party reviewer acts on behalf of the manufacturer, not as a representative of the FDA, can lead to compliance issues.
•Failing to prepare the 510(k) submission to the same standard as a direct FDA submission is a pitfall, as third-party reviewers adhere to FDA requirements and expectations.

Frequently asked questions

Generally, certain Class I and Class II devices that are well-understood and have established predicate devices are eligible, as defined by FDA product codes and program guidance documents.

Grouped by theme

Editor's picks

· Hand-selected related concepts

Regulatory

510(k) Premarket Notification(510(k))

FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.

Regulatory

Abbreviated 510(k)

510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.

More in Regulatory

· Same category

Regulatory

510(k) Summary vs 510(k) Statement

Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.

Regulatory

513(g) Request for Information(513(g))

Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.

Regulatory

Accreditation Scheme for Conformity Assessment(ASCA)

FDA voluntary program in which accredited testing labs perform standards-based testing accepted with reduced FDA scrutiny.

Regulatory

Additional Condition for Nonprescription Use(ACNU)

FDA framework for nonprescription drugs with approved additional conditions needed for appropriate self-selection or actual use when labeling alone is insufficient.

Cited by

Where this term appears across MedTech Terms.

Ecosystems (2)

Latest in MedTech

Sources

3 sources

Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

Tier 2Regulator guidance and consensus· 3

Link health: 3 verified· last checked 2026-06-20

FDA·1European Commission·1IMDRF·1

Inline markers like [1] jump to the matching reference above.

My progress

All terms0 / 513

Regulatory0 / 101

Saved on this device, and to your account when signed in. View studied terms

Full glossary

Browse all terms A to Z, each with a short definition.

On this term

Category: Regulatory
Acronym: 3P 510(k)
Sources: 3
Updated: 9/19/2026

Compare with another term

Learn in 60 seconds

Program in which FDA-accredited third parties conduct the initial 510(k) review for eligible device types.

·Used to compress timelines for well-established product types; not all product codes are eligible.
·Final clearance still rests with FDA.
·FDA usually decides within 30 days of receiving the recommendation.

Remember this

Watch out: A common pitfall is submitting an eligible 510(k) to a Third-Party Review Organization without ensuring the device falls within the specific product codes and limitations accepted by that particular organization.

Related terms

You may also need

Auto-suggested from Regulatory and shared keywords.

All Regulatory terms

From the Blue Goat network

Related resources and services on this topic.